Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Boccardi, Virginiaa; * | Paolacci, Luciaa | Remondini, Danielb | Giampieri, Enricob | Poli, Giuliac | Curti, Nicob | Cecchetti, Robertaa | Villa, Alfredod | Ruggiero, Carmelindaa | Brancorsini, Stefanoc | Mecocci, Patriziaa
Affiliations: [a] Institute of Gerontology and Geriatrics, Department of Medicine, University of Perugia, Perugia, Italy | [b] Department of Physics and Astronomy, University of Bologna, and INFN Bologna, Bologna, Italy | [c] Department of Experimental Medicine, Section of Terni, University of Perugia, Perugia, Italy | [d] Department of Clinical Pathology, S.M. della Misericordia Hospital, Perugia, Italy
Correspondence: [*] Correspondence to: Virginia Boccardi, MD, PhD, Institute of Gerontology and Geriatrics, Department of Medicine, University of Perugia, Piazzale Gambuli 1, 06132 Perugia, Italy. Tel.: +39 0755783524; E-mail: [email protected].
Abstract: Background:Elevated peripheral levels of different cytokines and chemokines in subjects with Alzheimer’s disease (AD), as compared with healthy controls (HC), have emphasized the role of inflammation in such a disease. Considering the cross-talking between the central nervous system and the periphery, the inflammatory analytes may provide utility as biomarkers to identify AD at earlier stages. Objective:Using an advanced statistical approach, we can discriminate the interactive network of cytokines/chemokines and propose a useful tool to follow the progression and evolution of AD, also in light of sex differences. Methods:A cohort of 289 old-age subjects was screened for cytokine and chemokine profiling, measured in plasma, after a thorough clinical and neuropsychological evaluation. A custom algorithm based on Fisher linear discriminant analysis was applied to ascertain a classification signature able to discriminate HC from mild cognitive impairment (MCI) and AD. Results:We observed that a joint expression of three proteins (a “signature” composed by IFN-α2, IL-1α, TNFα) can discriminate HC from AD with an accuracy of 65.24%. Using this signature on MCI samples, 84.93% of them were classified as “non-HC”. Stratifying MCI samples by sex, we observed that 87.23% of women were classified as “non-HC”, and only 57.69% of males. Indeed, in a scatter plot of IFN-α2 and IL-1α, the HC group was better separated from MCI and AD in women as compared with men. Conclusion:These findings suggest that AD is accompanied by a peripheral inflammatory response that can already be present in MCI subjects, thus providing a mean for detecting this at-risk status and allow an anticipated intervention.
Keywords: Cytokines, dementia, inflammation, markers, sex
DOI: 10.3233/JAD-190480
Journal: Journal of Alzheimer's Disease, vol. 72, no. 3, pp. 911-918, 2019
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]